Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
$2.2
5-499 Others
$1.8
500-999 Others
$1.5
≥1000 Others
Product Description
Probiotic Gummies are chewable dietary supplements formulated with live microorganisms intended to support a balanced intestinal microbiota and digestive wellness. Designed for supplement brands, retailers, and private-label programs, they combine consumer-friendly delivery with customizable probiotic strains, CFU targets, flavors, gummy bases, complementary ingredients, serving formats, and retail packaging.
Unlike many conventional nutritional gummies, probiotic gummies require special attention to microorganism viability. The meaningful specification is not only how many colony-forming units are added during production, but how many viable microorganisms remain through the intended shelf life. Strain selection, temperature exposure, moisture control, packaging, and storage therefore play a central role in commercial formulation.
| Item | Specification |
|---|---|
| Product Name | Probiotic Gummies |
| Product Category | Supplement Contract Manufacturing / Gummy Manufacturing |
| Dosage Form | Chewable gummy |
| Primary Active Ingredients | Selected probiotic strains or compatible probiotic blends |
| CAS Number | Not applicable to live probiotic microorganisms or the finished multi-ingredient gummy product |
| Molecular Formula | Not applicable to live probiotic microorganisms or the finished multi-ingredient gummy product |
| Molecular Weight | Not applicable to live probiotic microorganisms or the finished multi-ingredient gummy product |
| Finished Product Appearance | Uniform molded gummies with customizable color, flavor, shape, and surface finish |
| Probiotic Potency | Customized CFU target per gummy or serving according to strain selection and formulation requirements |
| Strain Identification | Specified to genus, species, and strain level where applicable to the selected probiotic material |
| Viability Specification | Defined according to the target viable CFU count through the intended shelf life |
| Gummy Base | Pectin or gelatin systems available according to formulation requirements |
| Flavor | Berry, strawberry, orange, mixed fruit, and other flavor profiles available |
| Sweetener System | Conventional, reduced-sugar, and other customized sweetener systems available |
| Test Method | Microbiological viable-count methods appropriate to the selected probiotic strain or blend |
| Quality Testing | Strain identity, viable CFU count, microbiological parameters, heavy metals, moisture, and finished-product quality testing as applicable |
| Manufacturing | Produced under GMP-standard conditions with formulation controls appropriate to probiotic stability |
| Shelf Life | Commonly up to 24 months when supported by strain stability, formulation, packaging, and validated storage conditions |
| Storage | Store in a cool, dry place away from direct sunlight, excessive heat, and moisture; storage requirements depend on the selected strains |
| Packaging | Bottles, jars, pouches, bulk packaging, and customized private-label formats with suitable moisture and environmental protection |
| MOQ | Flexible commercial quantities depending on strain system, CFU target, gummy format, packaging, and customization scope |
| Applications | Digestive wellness supplements, daily probiotic products, children's and adult gummy ranges, synbiotic concepts, and private-label nutritional programs |
For probiotic gummies, CFU specification is the most important buyer-decision point. A high microorganism count at the time of production does not automatically mean the product will deliver the same viable count months later. Viability can decline during processing and storage, so procurement specifications should distinguish between manufacturing input and guaranteed viable count over shelf life.
| Specification Point | What It Means | Procurement Relevance |
|---|---|---|
| CFU at Manufacturing | The viable microorganism count measured around the time the product is produced. | Useful for production control, but it does not by itself describe shelf-life potency. |
| CFU at Release | The viable count measured when the finished batch is released. | Provides batch-level quality information and should be linked to an appropriate test method. |
| CFU Through Shelf Life | The targeted viable count expected to remain within specification through the stated shelf life. | More meaningful for commercial product positioning and label consistency. |
| Strain-Level Identification | Defines the exact probiotic organism rather than using only a broad genus name. | Important because stability, processing tolerance, and scientific evidence can differ substantially by strain. |
| Overage | Additional viable microorganisms may be introduced to compensate for expected viability loss. | Should be based on strain behavior, manufacturing conditions, packaging, and stability data rather than a universal percentage. |
Two probiotic gummy products with the same declared CFU count can perform very differently during manufacturing and storage because probiotic organisms vary in heat, oxygen, moisture, and acid tolerance. Buyers should therefore evaluate strain identity, stability characteristics, viable count, and finished-product shelf-life targets together rather than selecting a formula only by the largest CFU number.
Spore-forming probiotics are often considered for gummy applications because some strains offer greater environmental stability than more sensitive vegetative microorganisms. However, strain suitability should always be assessed individually, and a strain used successfully in one dosage form should not automatically be assumed to perform identically in another.
Probiotic selection should begin with the desired product concept and the ability of the chosen organism to remain viable in the gummy matrix. Heat tolerance, moisture sensitivity, oxygen exposure, acidity, processing sequence, packaging, and target shelf life all influence strain suitability. The best commercial formulation is therefore based on compatibility rather than strain popularity alone.
Single-strain products can simplify stability assessment and label communication, while multi-strain formulations can support more differentiated concepts. When multiple organisms are combined, each strain should be evaluated for identity, viable count, compatibility, and contribution to the total CFU specification.
Probiotic Gummies can be formulated as probiotic-only supplements or developed into synbiotic concepts by combining compatible probiotic microorganisms with selected prebiotic ingredients. Prebiotic components may support formulation differentiation, but their inclusion must also be assessed for gummy texture, carbohydrate contribution, taste, moisture behavior, and serving-size practicality.
A synbiotic concept should be designed around meaningful formulation compatibility rather than simply adding multiple ingredients to the label. The probiotic CFU target and prebiotic quantity should both remain practical within the physical limits of the gummy dosage form.
OEM and private-label development can cover strain selection, CFU target design, formulation development, gummy-base optimization, flavor adjustment, pilot evaluation, finished-product manufacturing, labeling, and packaging. Probiotic projects require coordination between biological potency requirements and the physical properties of the gummy, making early specification development particularly important.
Commercial quantities are supported with flexible project structures. Actual production requirements vary according to probiotic strain system, target CFU count, formula complexity, gummy tooling, packaging components, and labeling requirements. Standard and customized programs can therefore be developed for different retail and distribution strategies.
Quality control for Probiotic Gummies should verify both conventional finished-product parameters and probiotic-specific attributes. Production under GMP-standard conditions can be supported by in-house R&D and testing, with viable-count monitoring and appropriate environmental controls incorporated according to the selected strains and formulation.
A commercially reliable probiotic gummy must protect microorganism viability while still delivering acceptable flavor, texture, appearance, and shelf stability. This requires coordinated decisions around strain selection, CFU target, manufacturing sequence, moisture management, packaging, and storage rather than treating the probiotic powder as a standard nutritional ingredient.
Packaging is a functional part of probiotic gummy development because moisture, oxygen, heat, and environmental exposure can affect microorganism viability. Bottles, jars, pouches, and other retail formats should therefore be evaluated for barrier performance as well as appearance. Storage instructions should reflect the actual stability characteristics of the selected probiotic strains.
Some probiotic systems may be suitable for ambient storage under controlled conditions, while others may require more stringent temperature management. Procurement teams should align the strain specification, packaging system, distribution conditions, and intended shelf life before finalizing the commercial product.
The target should be defined per gummy or per serving and should distinguish manufacturing input from the viable count intended through shelf life. Buyers should also specify the probiotic strain or strain blend, test method, serving size, packaging, and storage conditions so CFU quotations can be compared on a meaningful basis.
Probiotic microorganisms are living biological materials, and viability can decrease when they are exposed to unfavorable heat, moisture, oxygen, acidity, or storage conditions. The rate of decline varies by strain and formulation. Appropriate strain selection, process control, packaging, overage, and stability evaluation help manage this change throughout shelf life.
Some spore-forming probiotic strains are well suited to gummy development because they may tolerate processing and environmental exposure better than more sensitive organisms. However, suitability is strain-specific. The selected microorganism should still be evaluated for identity, viability, formulation compatibility, intended use, and target-market labeling requirements.
Yes. Compatible prebiotic ingredients can be incorporated to develop synbiotic gummy concepts. Their quantity should be balanced against gummy size, sweetness, carbohydrate contribution, texture, moisture behavior, and active loading. A commercially practical formulation should deliver meaningful ingredient levels without compromising probiotic viability or the consumer experience.
Commercial buyers commonly review the COA, TDS, SDS, probiotic strain identification, viable CFU test results, raw-material specifications, and relevant quality documentation. For finished gummies, procurement teams should also align the end-of-shelf-life potency target, serving size, packaging configuration, storage conditions, and applicable label requirements before production.
Probiotic Gummies provide a consumer-friendly format for digestive wellness and microbiome-focused supplement programs, but their commercial quality depends heavily on microorganism viability. Aligning strain identity, CFU target, gummy processing, moisture management, packaging, storage, and shelf-life expectations from the beginning creates a more reliable private-label product specification.
Contact us today to request samples, technical documents, formulation support, and a wholesale quotation for Probiotic Gummies.

Packaging & Delivery
The file is encrypted. Please fill in the following information to continue accessing it